Abstract:Fearnley et al reported an ataxia case with a 46 of 29 CAG repeats in THAP11, comorbid with a 22-CAG repeat expansion in CACNA1A from European-ancestry ataxia cohort. This patient was diagnosed as hereditary ataxia at the age of 40 and Parkinson's disease at 53. The comorbidity of two polyglutamine (polyQ) diseases may complicate the phenotype and further assessment is warranted. Nevertheless, this is the first time that CAG expansion greater than 45 repeats in THAP11 was found beyond Chinese ataxia population. Therefore, this patient further confirmed this new subtype of spinocerebellar ataxia (SCA). In addition, Fearnley et al also investigated the normal expansion ranging from 19 to 39 repeats in THAP11 from 2504 individuals in 1000 Genomes. In general, these findings suggest that ATX-THAP11 is not limited to Asian. As the latest SCA included in Online Mendelian Inheritance in Man (OMIM) is SCA50, the new SCA subtype caused by the CAG expansion in THAP11 identified by us is appropriately named ATX-THAP11/SCA51. The pathogenic mechanism of polyQ diseases is widely attributed to the toxicity of abnormal proteins containing stretches of polyQ residues.1 We observed an increase in the length of glutamine correlates with a more severe phenotype in our ATX-THAP11/SCA51 family.2 Interestingly, expansion of CAG repeats interrupted by CAA is common in polyQ disease, which encodes the same glutamine for polyQ stretch, but may lead to distinct RNA secondary structures.1 In recent years, several reports have explored the impact of various DNA structures within CAG repeats on the severity of polyQ diseases. Three independent studies have reported that in individuals with Huntington's disease (HD), a reduction in CAA insertions and an increase in uninterrupted CAG repeats are associated with an earlier onset age of HD.3, 4 Conversely, increased CAA insertions are linked to delayed disease onset.3 Further comparisons among different HD mouse models have demonstrated that longer uninterrupted CAG repeats are associated with striatum-selective transcriptionopathy, possibly because of CAG repeat instability and nuclear aggregation.5 Another intriguing observation is that pure CAG repeats in ATXN2 are associated with SCA2, whereas CAG repeats in ATXN2 causing amyotrophic lateral sclerosis (ALS) and Parkinson's disease are predominantly interrupted by CAA.6 In Drosophila models, ataxin-2 encoded by pure CAG repeats induces retinal and neurotoxicity, whereas CAA insertions or only CAA repeats do not induce toxicity, despite producing the same protein.7 In our large family affected by ATX-THAP11/SCA51, we noted a decrease in CAA insertions and an increase in pure CAG length. However, there was no decrease in CAA insertions in our other family or in the patient reported by Fearnley et al. Currently, because of the limited number of ATX-THAP11/SCA51 patients, whether CAA interruption modulates pathogenesis of polyQ aggregation and influences clinical phenotypes needs further exploration. In the future, it is necessary to detect CAG repeat expansion of THAP11 across ethnically and geographically different ataxia populations to clarify its genotype–phenotype characteristics and pathogenesis of ATX-THAP11/SCA51. The author declares that the research was conducted in the absence of other commercial or financial relationships that could be construed as a potential conflict of interest. (1) Research project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript: A. Writing of the First Draft, B. Review and Critique. H.X., H.J., and N.Z. contributed to the conception and design of the study, as well as reviewed the draft; D.T., W.J., and Z.C. contributed to the analysis of data and drafting of the text. Not applicable.

Overexpanded CAG repeats in ATN1 cause an Early-Onset Case of Dentatorubral-Pallidoluysian atrophy with novel phenotypes and a literature Review of Chinese patients

[Genetic and Clinical Analysis in a Parkinson's Disease Family Caused by Expansion of SCA2].

[Genetics and Clinical Study of Chinese Kindreds with Dentatorubral Pallidoluysian Atrophy].

Clinical and genetic characteristics of patients with dentatorubro-pallidoluysian atrophy]

Clinical and genetic study of two families with dentatorubral-pallidoluysian atrophy

The Case Report on Dentatorubral?Pallidoluysian Atrophy

Research on the normal range of CAG repeats of dentatorubropallidoluysian atrophy gene in Han population of South China mainland

Intronic (tttga)n Insertion in SAMD12 Also Causes Familial Cortical Myoclonic Tremor with Epilepsy

Identification Of C9orf72 Repeat Expansions In Patients With Amyotrophic Lateral Sclerosis And Frontotemporal Dementia In Mainland China

Long-read sequencing identified intronic (GGCCTG)n expansion in <i>NOP56</i> in one SCA36 family and literature review

The genetic landscape and phenotypic spectrum of GAA- FGF14 ataxia in China: a large cohort study

Studies gin the CTA/CTA/CTG trinucleolide repeats of ATXNSOS gene in Chinese Hans

Long-read Sequencing Identified Intronic (ggcctg)n Expansion in NOP56 in One SCA36 Family and Literature Review

Genetic and Clinical Analyses of Spinocerebellar Ataxia Type 8 in Mainland China

Reply To: "THAP11 CAG Expansion Beyond Chinese-Ancestry Cohorts: an Examination of 1000 Genomes and UK Biobank"

De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome

Two Distinct Clinical Features and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients with TARDBP Gene Mutations in the Chinese Population

Insights into Dentatorubral-Pallidoluysian Atrophy from a new Drosophila model of disease

Familial FTD in China:progress and Prospects

DRPLA gene (atrophin-1) sequence and mRNA expression in human brain.

ATXN 2 CAG Repeat Expansions Increase the Risk for Chinese Patients with Amyotrophic Lateral Sclerosis